chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Weeks after my first dose of Pfizer covid 19 vaccine I began having teary red eyes and sneezing disturbances. I went to my doctor and he ran  allergy test, to my surprise there are lists of materials that creating allergies in me now. I am never allergic to anything in the past at least not to my knowledge.
Headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ATOGEPANT for Migraine.    Concurrent medical conditions included Migraine.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form and ATOGEPANT (unknown route) 60 mg once a day. On 06-Dec-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced HEADACHE (Headache). At the time of the report, HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient ran out of Qulipta . She took it for 12 days No treatment medications reported
lightheaded (slight);  reported feeling slightly/ mild lightheadedness .   5 mins. post vaccination.   Relates symptoms to minimal fluid intake (only coffee) & very small breakfast.  Symptom resolved with mask removal, fresh air, entire bottle of water, reclining. of car seat.  Able to return to upright position without adverse effects.  Drove off lot independently after another 15 mins.
I had the symptoms of hand foot and mouth on 11-13-2021. This included a rash with bumps on my hand feet and chest with a really high fever of 103.1. I was off work sick until November 19, 2021. The bumps turned into blisters that were extremely painful and it stretched to my face, mouth, nose and throat and tongue. I saw the doctor on 11-13-2021 and was diagnosed with hand foot and mouth. The doctor advised me to gargle with salt water and use OTC Aquaphor to treat. All my nails fell off. I am still losing the nails on my toes. I communicated this information thru my chart.  All the blisters and bumps healed. I got my 2nd dose of the vaccine on November 26, 2021-(fj875-Pfizer). After this, I  started getting sore throat and I was tired with congestion on February 15, 2022. The symptoms got worse daily with a fever as high as 102.8. I was diagnosed with pneumonia On February 19, 2022. I took a PCR test negative for COVID 19. However my at  home kit tested positive on February 17,2022.  I am currently undergoing a lot of treatments now. I started amoxicillin on February 20th and was only on it 1 day when the doctor prescribed prednisone, clarithromycin benzoate and a probiotic. I still have a lot of wheezing chest cracking and its hard to breath. I am dizzy tired and very short of breath. I am going for a chest x-ray and a pulmonary function test on Friday. I am still unable to return to symptoms. On February 09, 2022, I had to go to a cardiologist for breathing issues and was diagnosed with Premature ventricular contraction. No treatment was provided.
Patient diagnosed 01/2023 with adenocarcinoma, either appendiceal or colonic.  Final pathology pending.
Information has been received from a physician concerning an "over 65 years old" patient who was vaccinated with PNEUMOVAX 23 (lot number not available). Subsequently the patient "experienced swelling at the injection site and was hospitalized for an unspecified length of time due to this reaction". At the time of the report, the patient recovered from swelling at the injection site. Attempts are being made to obtain additional identifying information to distinguish the individual patients mentioned in this report. Additional information will be provided if available. This is one of several reports received from the same source. Additional information has been requested.
on 3/22/2021 pt developed altered mental status, right sided weakness,  right sided gaze, aphasic.  Patient was administered 65 mg IVPB alteplase 3/22 1245 with last known well 3/22 1000.  Received Covid vaccine 3/18/21.  Pt was usual state of health prior to stroke with no illnesses.  initial NIH score was 18.  post tpa NIH of 12 am of 3/23.
Developed redness, hot, swelling, itching,  at injection site on 10th day after shot.  Lasted about 5 days
Pt states she developed inflammation on left upper arm, including redness, swelling, throbbing and itching within about 4-5 hours, post vax. Area also was warmer than surrounding portion of upper arm. Pt states these symptoms became more pronounced in the next 36 hours. States also has some soreness in left neck. Saw MD on 10/19/00. He advised ice pack application.
Pt's mother reports 2 days after Prevnar, Comvax, MMR, Varivax child developed 'hives' over lower extremity. Child now fine. Hives resolved with Tylenol and Augmentin at same time.
SICK; BAD SORE THROAT; BODY ACHES; CHILLS; FEVER; HEADACHE; FATIGUE; This spontaneous report received from a consumer via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company was unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the patient experienced sick, bad sore throat, body aches, chills, fever, headache, and fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sick, bad sore throat, body aches, chills, fever, headache, and fatigue. This report was non-serious.
Swelling, nodule formation in (L) arm, deltoid area. Warm and painful to touch.
Patient was to receive Flucelvax and instead stronger 65+ was administered. As per guidelines and research, more stronger local side effects were observed.
16 year old, female patient who was administered with the Moderna Covid-19 vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old, female patient who was administered with the Moderna Covid-19 vaccine) in a 16-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient had a liver transplantation before first dose of vaccine.  Concurrent medical conditions included Immunocompromised.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Mar-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Mar-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old, female patient who was administered with the Moderna Covid-19 vaccine). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old, female patient who was administered with the Moderna Covid-19 vaccine) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications was not provided by the reporter. Treatment information was not provided.   This case was linked to MOD-2022-569133, MOD-2022-569131, MOD-2022-569129 (Patient Link).
Prior to administration, I asked the pt. if she had any signs or symptoms with previous vaccine given and if she had eaten. Patient stated she had eaten and had no prior signs or symptoms. Approximately 5 minutes after vaccination of vaccines, the pt. complained of severe headache. Ten minutes later, she complained of nausea, lightheadedness, chest pain and abdominal pain. She appeared flushed and clammy. Vital signs (pulse, temp and blood pressure) were taken and were all normal. Dr. evaluated the patient and asked the pt. to remain in the office for 15-20 minutes longer (it had been 40 minutes at this point). Pt. did state to Dr. that she had chest pain and abdominal pain with the first 2 injections lasting 24 hours. Dr. released the pt. to grandfather's are with mother's knowledge. He was advised to have mom call us with an update. Total time spent in the office, after vaccine was given, was approximately 60 minutes.
PER PT DESCRIPTION:I got the vaccine around 11 am last Friday. Thanks to you, I was calm and relaxed during the vaccination. I was fine and was able to return home safe. However, at around 5 pm, I felt a sudden pain on my right leg. My leg felt hot, became red, and had a big lump or swelling which was about 10 cm. The leg was not just feeling hot but was also hard like board. And I could not move my leg. I was really scared, and was thinking of calling an ambulance. Thankfully, everything went back to normal after 5 minutes - no pain, no swelling, no reddish color, and I was able to move my leg. However, after 30 minutes, the same thing happened to my left leg. But the pain was a little weaker and I could still move it despite the pain. The left one was not so bad compared with right one. And a few minutes after, my left leg was fine. Everything was okay like nothing happened. I did not notice any mark on any of my legs.   However, at around 9 pm, I looked at my leg and I noticed a circular trace/mark which was about 10 cm on my right leg. Please see the photo attached.
1-2 min following injection, patient felt cool, clammy, no s/s of dizziness, no fainting, + nausea, - vomiting, color pale. 6:20 sitting up, verbal, good skin color, no N/V, no dizziness.
This spontaneous report as received from a nurse refers to a 11 month old patient. The patient's medical history was not reported. On 16-OCT-2014 the patient was vaccinated with first dose of M-M-R II and VARIVAX (Merck) (dose, frequency and lot # were not reported). No adverse symptoms were reported. No product complaint was reported for M-M-R II and VARIVAX (Merck). Additional information has been requested.
A non-serious spontaneous report of "nurse got H1N1 in my eye" and " it is a little red" has been received from a consumer concerning a 41-year-old female, subsequent to H1N1, intranasal. Neither relevant medical history nor concomitant medications have been reported for this patient. On 27-Oct-2009, the patient received H1N1. The patient reported that a nurse got H1N1 vaccine in the patient's eye. Her eye was a little red but not painful. The patient washed her eye with normal saline. The outcome for the reported adverse event was not reported.
Swelling of left upper arm noted by mother one day after vaccines administered.  Mother reports 2 vaccines were given in left arm and one in right.  Child is fussy but not toxic, with complaint of itching.  Treated with Benedryl and ice to area.  Vaccine provider information differs from parent's information in regard to site of vaccinations.
LOST SMELL COMPLETELY; ENERGY LEVELS DROPPED SIGNIFICANTLY AFTER SHOT; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's past medical history included: covid-19. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the patient experienced lost smell completely, and energy levels dropped significantly after shot. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from lost smell completely, and the outcome of energy levels dropped significantly after shot was not reported. This report was non-serious.
This spontaneous report as received from a pharmacist refers to a 65 year old patient of unknown gender. Medical history and drug reactions/allergies were not reported. On 23-APR-2014, the patient was vaccinated with VARIVAX (Merck), 0.5 ml subcutaneous (lot not reported), in place of ZOSTAVAX. Concomitant medication was not reported. No adverse effect reported. This is one of two reports from the same source (1405USA007734). Additional information has been requested.
Short-term memory loss, slurred speech, disorientation, flashes of black when trying to speak/trying to concentrate, lose train of thought when speaking/could not speak, stutter/shakiness in voice when speaking, frequent pauses because I would forget the word in a sentence I was trying to say, headaches/dizziness, fever
Patient passed out abruptly while driving. Went to the hospital - no specific cause for dizziness and syncope was found.
This spontaneous report was received from a physician via a company representative, referring to a 21 month old female patient. The patient's concurrent conditions and medical history were not reported. In approximately June 2016 (reported as a year ago), the patient was vaccinated with VARIVAX (dose, route, lot number and expiration date not reported) to prevent chicken pox. There was no concomitant medication reported. The parents of the patient reported to the physician that their daughter developed a case of shingles on an unspecified date in June 2017 (reported as later last week). The parents reported that their daughter was also seeing a dermatologist for "the itchy skin" and the "bad rash" and she was also receiving treatment for the adverse event. It was also reported that an unspecified test was done and results came back as herpes zoster. The outcome of herpes zoster was reported as not recovered. The causality between the herpes zoster and the VARIVAX was not provided.
No additional AE's; A medical assistant reported that a dose of improperly stored PROQUAD was administered to a patient.    ?; This spontaneous report has been received from a medical assistant, regarding to a patient of unknown gender and age. The patient's pertinent medical history, concurrent conditions, concomitant medications, and previous drug reactions or allergies were not reported.   On 21-SEP-2022, the patient was vaccinated with improperly storage dose of measles, mumps, rubella and varicella (Oka-Merck) virus vaccine live (rHA)(PROQUAD) injection, administered as prophylaxis (lot number W012729 which has been verified to be valid, expiration date reported and validated as 16-OCT-2023) (strength, dose, route of administration, and anatomical site of injection were not reported).   Administered doses were stored at a temperature of 55.5 degrees Fahrenheit (F) (also reported as above 46F for 1 hour) during a time frame of 10 hours. There was no previous temperature excursion. No additional adverse events were reported in the patient.
underlying inflame arthritis Left knee pain, swelling Aspiration L knee  3/8/21 2525 WBC /75% PMN Asp. L knee 5/3/21  3813 WBC / 82% PMN
This spontaneous report as received from a healthcare worker refers to a patient of unknown age and gender. Pertinent medical history, drug allergies or reactions were not reported. On 29-SEP-2014, the patient was vaccinated with an expired dose of M-M-R-II lot # H017437, expiry date: 20-SEP-2014, 0.5 ml, subcutaneous. No adverse effects had been observed or reported. Additional information has been requested.
extreme tiredness, brain fog and memory lapses, redness and blister on arm , NOTE: After a week, still very  tired
I have been coughing since receiving the vaccine.  My allergies place me on Flonase but no relief. I went to  MD now on in December due to ongoing coughing. Placed on Z pack and Tessalon but no relief.
The day after I got the vaccine my chest started to feel heavy and my heart was having many palpitations. It's a month later and the symptoms have not let up at all. It's actually getting worse.
Flu vaccine given 12/11/06 0.5 cc IM Right deltoid. Patient stated that by 8pm he experienced breathing problem and had to use his inhaler-he could not cough anything up.-episode lasted approximately one hour. The next day he felt "washed out". Has no allergy to eggs.
Felt chills; Felt a little bit nauseous; Tired; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS, NAUSEA, and FATIGUE in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 9399021) for COVID-19 vaccination.     Concurrent medical conditions included Asthma and Obesity.    On 31-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Nov-2021, the patient experienced CHILLS, NAUSEA, and FATIGUE. At the time of the report, CHILLS, NAUSEA, and FATIGUE outcome was unknown.            No concomitant medications were reported. No treatment medications were reported. Patient stated that she is not immunocompromised. Patient didn't seem sure if she got the full dose or half a dose.
5/13/10-watery, loose stools x 4, 5/14/10 x 9 stools diarrhea-seen at site 5/14/10 - stool was + pos. for occult blood. 5/15/10 - 5/16/10 3-4 per day green watery stools. Seen in office 5/18/10 with increased spitting. Seen 5/20/10 with increased sleeping, fussy and fever 99.7 ( R ). Labs for stool culture/Rotavirus 5/19/10 to Lab.
PATIENT EXPERIENCE LIGHT-HEADEDNESS AND DIZZINESS 5 MINUTES AFTER RECEIVING VACCINE. PATIENT ALSO FELT LIKE PASSING OUT. EMT WAS CALLED IN AND TOOK OVER CARE OF PATIENT.
No adverse event; Expired dose administered to patient; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired dose administered to patient) and NO ADVERSE EVENT (No adverse event) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L21B) for COVID-19 prophylaxis.     No Medical History information was reported.    In 2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. In 2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired dose administered to patient). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired dose administered to patient) and NO ADVERSE EVENT (No adverse event) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired dose administered to patient).    No concomitant medication information was provided.  The vial was initially stored in refrigerator on 07-Jun-2022.  The vial did not undergo any temperature excursions.  The patient was administered on any one of these dates (vaccine administration dates) of 01-Apr-2022, 05-Apr-2022, 06-Apr-2022, 08-Apr-2022, 11-Apr-2022, 12-Apr-2022, 13-Apr-2022, 14-Apr-2022, 22-Apr-2022, 09-Jun-2022, 10-Jun-2022, 13-Jun-2022, 18-Jun-2022 and 22-Jun-2022.  No treatment information was provided.
Seven to ten days post vax, pt developed a painful, non-migratory polyarthritis of the large and small joints. Pt also developed some fever, rash and high acute phase reactants.
After receiving immunizations the patient passed out for a period <2min. Due to this she fell off the exam table. Was slow to respond immediately following incident. Only complaint was back pain, she was sent to ED for evaluation.
shingles; Information has been received from a lawyer regarding a case in litigation concerning a female patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided.  On or about 10-OCT-2011, the patient (pt) was vaccinated with zoster vaccine live (ZOSTAVAX), (lot# and route unknown) for long-term prevention of shingles and zoster-related conditions.  Subsequent to zoster vaccine live (ZOSTAVAX) inoculation, the pt experienced shingles (date unspecified) and was treated by a physician at her office, and was hospitalized due to the event (date unspecified). As a direct and proximate result of pt use of the zoster vaccine live (ZOSTAVAX) vaccine, the pt had and would continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future. The outcome of the event was considered as not resolved. The reporter considered the event to be related to zoster vaccine live (ZOSTAVAX).
Sore throat; started to experience aches; Harsh dry cough; This is a spontaneous report from a contactable consumer (patient). A 50-years-old male patient received BNT162B2, via an unspecified route of administration, administered in Arm Right on 22Feb2021 11:00 (Lot Number: EN6200), at the age of 50-years-old, as dose 1, single for COVID-19 immunisation. Medical history included sinus drainage from allergies from an unknown date and unknown if ongoing. There were no concomitant medications. The patient previously had his flu vaccine about 8 weeks ago. On 23Feb2021 10:00, the patient experienced sore throat, started to experience aches and harsh dry cough. The clinical course was reported as follows: Patient received first dose of Pfizer Covid vaccine on 22Feb2021 about 11am. He woke up this morning about 10am with a sore throat and a harsh dry cough. On 23Feb2021 started to experience aches, sore throat, and dry cough. He knows these are not reported side effects in the clinical trials but wants to know if he could transmit the virus after receiving the vaccine. He is a caretaker for his mother who has respiratory issues and he wants to be safe for when she returns home from the hospital later this week. States that he is constantly keeping a Halls cough drop in his mouth and is trying to keep his throat moist so he doesn't hack so hard. Therapeutic measures were taken as a result of all the events. The outcome of the events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Monovalent COVID-19 vaccine was administered as a booster shot instead of abivalent. Patient did not having an adverse event or outcome.
Patient was fully vaccinated with Moderna 3/5/21 and 4/2/21.  Patient had fatigue, abdominal pain, diarrhea, and N/V. She states that the N/V and diarrhea have felt off and on for the past few weeks but have increased in past week. Patient was admitted 1/14/22 and is still admitted with COVID
pt recvd vax 10DEC92 & began having sz & a molitide of reacts; pt is extremely handicapped as a result;
Breakthrough case after 5 vaccines  Moderna 3/3/21 Lot# 043L20A;  Moderna 3/31/21 Lot# 010A21A;  Moderna 10/6/21 Lot# 039D21A;  Moderna 4/15/22 Lot# 033K21-2A;  Pfizer 9/20/22 Lot# Gj3277
Vaccinee rec'd 1st doses of Engerix-B on 12SEP90 & 6 hrs later had onset of heart palpitations; Seen in ER; 13SEP90 palpitations were persisting, & a temp of 99.3 was noted;
Around the 26th or 28th, got flu-like symptoms. Felt crummy. Got "bumps" on face. Can't really see but could feel them. No energy. Left side of face near eye, up to hairline. Went to dr's on 10/3 and diagnosed with shingles.